8月3日(周二),礼来高开高走,盘中股价触及历史新高。该公司表示,有信心在年底向FDA提交阿尔茨海默病药物的申请,希望能尽快上市。
今年年初时,该公司公布了旗下试验性阿尔茨海默氏症药物的积极数据。公司表示,与服用安慰剂的患者相比,在18个月过后,其药物donanemab令患者记忆力和日常生活活动能力的下降速度减缓了32%。
老虎资讯综合2021-08-03
8月3日(周二),礼来高开高走,盘中股价触及历史新高。该公司表示,有信心在年底向FDA提交阿尔茨海默病药物的申请,希望能尽快上市。
今年年初时,该公司公布了旗下试验性阿尔茨海默氏症药物的积极数据。公司表示,与服用安慰剂的患者相比,在18个月过后,其药物donanemab令患者记忆力和日常生活活动能力的下降速度减缓了32%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial